Vision-related quality of life with myopia management: A review

The disease of myopia has come into focus as a worldwide public health concern. Myopia has shown increasing prevalence, incidence at earlier age and progression to a higher degree. Progressive increase in degree of myopia is strongly associated with increase in axial length of the eye. Various interventions have been shown to slow axial elongation in children. These interventions have been studied to assess efficacy in slowing axial elongation and correction of vision. In addition, research into quality of vision, risk of adverse events, overall safety and impact on vision-related quality (VR-QoL) of life has been pursued. In contrast, studies have been published to demonstrate the risks of myopia, high myopia and increased axial length. This review will discuss VR-QoL assessment on the most effective and most commonly prescribed interventions to slow axial elongation and myopia progression. The patient attributes considered are VR-QoL scores from validated instruments. The development and use of validated survey instruments to assess the patient-reported outcomes is discussed. The review demonstrates that there are numerous factors that may impact VR-QoL to evaluate in the decision-making process when eye care providers consider when, how and if to prescribe myopia management (MM) for children with myopia.

Automated summary

Myopia has become a global public health concern, with increasing prevalence, onset at an earlier age, and progression to a higher degree. The progression of myopia is strongly associated with axial length elongation. Numerous interventions have been studied to slow axial elongation and correct vision in children. Research has also focused on the impact of these interventions on quality of vision and vision-related quality of life. In contrast, studies have highlighted the risks of myopia, high myopia, and increased axial length. This review discusses the assessment of vision-related quality of life in determining the most effective interventions for managing myopia progression. Validated instruments are used to assess patient-reported outcomes, and factors that may impact vision-related quality of life are considered in the decision-making process.